Despite differences in gene alterations between ALK+ ALCL and ALK- ALCL, they share some deregulated transcription factors programs like STAT3 and NOTCH1 activation, IRF4, and c-MYC overexpression (9, 26–29). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.